Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

PURPOSE: Allogeneic hematopoietic cell transplantation (HCT) after high-dose conditioning regimens imposes prohibitively high risks of morbidity and mortality for patients with high-risk acute myeloid leukemia (AML) who are older or have comorbid conditions. Here, we examined outcomes after nonmyelo...

詳細記述

保存先:
書誌詳細
主要な著者: Gyurkocza, Boglarka, Storb, Rainer, Storer, Barry E., Chauncey, Thomas R., Lange, Thoralf, Shizuru, Judith A., Langston, Amelia A., Pulsipher, Michael A., Bredeson, Christopher N., Maziarz, Richard T., Bruno, Benedetto, Petersen, Finn B., Maris, Michael B., Agura, Edward, Yeager, Andrew, Bethge, Wolfgang, Sahebi, Firoozeh, Appelbaum, Frederick R., Maloney, David G., Sandmaier, Brenda M.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2010
主題:
Original Reports
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903320/
https://ncbi.nlm.nih.gov/pubmed/20439626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.1460
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料